Mrsa Mechanism
Mrsa Mechanism - Related Videos
01:25
Mechanism of Antibiotic Resistance in MRSA
0 Views •
2026
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
07:46
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
0 Views •
Cited by 13 •
2012
Experimental rat endocarditis model due to methicillin-resistant S. aureus.
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
0 Views •
Cited by 23 •
2011
Murine skin and soft tissue infection model is utilized for assessing the virulence function of methicillin resistant Staphylococcus aureus (MRSA) and the host immunological responses. Here, we presented a subcutaneous infection model for skin and soft tissue infection.
12:45
Mechanical Stimulation of Chondrocyte-agarose Hydrogels
0 Views •
Cited by 29 •
2012
The biosynthesis of cartilaginous extracellular matrix by chondrocytes can be affected by application of mechanical stimuli. This method describes the technique of applying dynamic compressive strains to chondrocytes encapsulated in 3D constructs and the evaluation of induced changes in chondrocyte metabolism.
03:06
Reaction Mechanisms
0 Views •
2020
Chemical reactions often occur in a stepwise fashion, involving two or more distinct reactions taking place in a sequence. A balanced equation indicates the reacting species and the product species, but it reveals no details about how the reaction occurs at the molecular level. The reaction mechanism (or reaction path) provides details regarding the precise, step-by-step process by which a reaction occurs. For instance, the decomposition of ozone appears to follow a mechanism with two steps:
FAQs
PBP2a preserves cell-wall synthesis during beta-lactam exposure because the protein has low affinity for these antibiotics. The mecA gene encodes this altered penicillin-binding protein, so the drug cannot effectively disrupt the activity needed for continued wall construction. This molecular link explains the resistance phenotype and provides a target for laboratory detection.
SCCmec is important because it carries mecA, linking the genetic basis of resistance to a defined mobile element in the bacterium. Its presence helps explain how the resistance determinant is identified as part of the organism’s biology rather than as a temporary response to antibiotic exposure. This context supports molecular detection and interpretation of MRSA findings.
Low affinity matters because PBP2a remains functionally available when beta-lactam antibiotics are present. Instead of being effectively inhibited, this altered penicillin-binding protein supports continued cell-wall synthesis, allowing bacterial growth-related processes to persist under treatment pressure. Recognizing this relationship helps explain why beta-lactam exposure alone may not produce the expected susceptibility result.
Laboratory investigation can examine either the genetic or protein-level consequence of resistance. Detecting mecA or identifying PBP2a provides evidence for the altered target, while antimicrobial susceptibility testing evaluates how the isolate responds to beta-lactam exposure. Combining these approaches connects the biological mechanism with results that support clinical interpretation and infection-control decisions.
Antimicrobial susceptibility testing shows the isolate’s observed response to antibiotic exposure, complementing detection of the mecA-PBP2a pathway. This distinction matters because genetic or protein evidence describes the resistance mechanism, whereas susceptibility results help determine how that isolate should be interpreted for treatment decisions. The combined information supports selection of effective therapy rather than relying on one result alone.
The mechanism connects a specific resistance determinant with survival during exposure to many beta-lactam antibiotics, making its recognition relevant beyond individual treatment. Laboratory detection and susceptibility results can support decisions intended to limit transmission, while understanding the same process helps frame infection-control concerns in both healthcare and community settings. This links molecular microbiology with prevention efforts.